Status:
RECRUITING
Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Conditions:
ADHD
Immune System
Eligibility:
All Genders
6-12 years
Brief Summary
The goal of this observational study is to learn about The immune cell landscape of peripheral blood mononuclear cells in children with ADHD compared to typically developing controls. The main questio...
Detailed Description
3.1 Research Content Peripheral blood mononuclear cells of ADHD children and control group were taken, and 41 protein Marker on the cell surface was detected and analyzed by mass spectrometry flow cyt...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ADHD； Children with an IQ≥70； Both parents are Han； Agree to take venous blood with informed consent；
Exclusion
- Schizophrenia, mood disorder, autism, mental retardation； Obvious physical and nervous system abnormalities；
Key Trial Info
Start Date :
December 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06109337
Start Date
December 4 2023
End Date
December 1 2027
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fu Guanghui
Hangzhou, Zhejiang, China, 310000